1. Home
  2. CRNX vs GSAT Comparison

CRNX vs GSAT Comparison

Compare CRNX & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRNX
  • GSAT
  • Stock Information
  • Founded
  • CRNX 2008
  • GSAT 2003
  • Country
  • CRNX United States
  • GSAT United States
  • Employees
  • CRNX N/A
  • GSAT N/A
  • Industry
  • CRNX Biotechnology: Pharmaceutical Preparations
  • GSAT Telecommunications Equipment
  • Sector
  • CRNX Health Care
  • GSAT Consumer Discretionary
  • Exchange
  • CRNX Nasdaq
  • GSAT Nasdaq
  • Market Cap
  • CRNX 2.8B
  • GSAT 3.4B
  • IPO Year
  • CRNX 2018
  • GSAT 2006
  • Fundamental
  • Price
  • CRNX $29.20
  • GSAT $25.00
  • Analyst Decision
  • CRNX Strong Buy
  • GSAT Strong Buy
  • Analyst Count
  • CRNX 8
  • GSAT 3
  • Target Price
  • CRNX $74.86
  • GSAT $43.33
  • AVG Volume (30 Days)
  • CRNX 806.6K
  • GSAT 575.0K
  • Earning Date
  • CRNX 08-07-2025
  • GSAT 08-11-2025
  • Dividend Yield
  • CRNX N/A
  • GSAT N/A
  • EPS Growth
  • CRNX N/A
  • GSAT N/A
  • EPS
  • CRNX N/A
  • GSAT N/A
  • Revenue
  • CRNX $760,000.00
  • GSAT $253,901,000.00
  • Revenue This Year
  • CRNX $409.34
  • GSAT $6.34
  • Revenue Next Year
  • CRNX $773.02
  • GSAT $20.67
  • P/E Ratio
  • CRNX N/A
  • GSAT N/A
  • Revenue Growth
  • CRNX N/A
  • GSAT 14.55
  • 52 Week Low
  • CRNX $24.10
  • GSAT $15.00
  • 52 Week High
  • CRNX $62.53
  • GSAT $41.10
  • Technical
  • Relative Strength Index (RSI)
  • CRNX 37.84
  • GSAT 49.30
  • Support Level
  • CRNX $27.60
  • GSAT $22.35
  • Resistance Level
  • CRNX $31.50
  • GSAT $24.89
  • Average True Range (ATR)
  • CRNX 1.21
  • GSAT 0.98
  • MACD
  • CRNX -0.33
  • GSAT -0.40
  • Stochastic Oscillator
  • CRNX 9.89
  • GSAT 35.75

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: